IBRX
NASDAQ · Biotechnology
Immunitybio Inc
$7.64
+0.32 (+4.37%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+10.25%
1Y
+213.11%
YTD
+278.22%
Open$7.40
Previous Close$7.32
Day High$7.65
Day Low$7.25
52W High$12.43
52W Low$1.95
Volume—
Avg Volume10.72M
Market Cap7.93B
P/E Ratio—
EPS$-0.85
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$4.22
Above
SMA 200
$2.95
Above
RSI (14)
70.9
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
10 analysts
Price Target
+1,324.0% upside
Current
$7.64
$7.64
Target
$108.79
$108.79
$71.54
$108.79 avg
$142.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 127.84M | 1.55B | 1.61B |
| Net Income | -396,378,785 | 174.18M | 206.87M |
| Profit Margin | -310.2% | 11.2% | 12.9% |
| EBITDA | -271,343,068 | 310.76M | 319.11M |
| Free Cash Flow | — | 125.72M | 219.44M |
| Rev Growth | +678.6% | +14.4% | +15.1% |
| Debt/Equity | 0.01 | 0.68 | 0.80 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |